217 related articles for article (PubMed ID: 10393366)
1. A correlative study of gliomas using in vivo bromodeoxyuridine labeling index and computer-aided malignancy grading.
Sharma S; Karak AK; Singh R; Mehta VS; Sarkar C; Schmitt HP
Pathol Oncol Res; 1999; 5(2):134-41. PubMed ID: 10393366
[TBL] [Abstract][Full Text] [Related]
2. A grading study of gliomas using computer aided malignancy classification and histologic morphometry.
Sharma S; Karak AK; Sarkar C; Gomathy G; Banerji AK; Schmitt HP
J Neurooncol; 1996 Jan; 27(1):75-85. PubMed ID: 8699229
[TBL] [Abstract][Full Text] [Related]
3. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
[TBL] [Abstract][Full Text] [Related]
4. Apparent diffusion coefficient in the evaluation of cerebral gliomas malignancy.
Ignjatović J; Stojanov D; Zivković V; Ljubisavljević S; Stojanović N; Stefanović I; Benedeto-Stojanović D; Ignjatović N; Petrović S; Aracki-Trenkić A; Radovanović Z; Lazović L
Vojnosanit Pregl; 2015 Oct; 72(10):870-5. PubMed ID: 26665552
[TBL] [Abstract][Full Text] [Related]
5. Correlation between bromodeoxyuridine-labeling indices and patient prognosis in cerebral astrocytic tumors of adults.
Fujimaki T; Matsutani M; Nakamura O; Asai A; Funada N; Koike M; Segawa H; Aritake K; Fukushima T; Houjo S
Cancer; 1991 Mar; 67(6):1629-34. PubMed ID: 2001552
[TBL] [Abstract][Full Text] [Related]
6. Pediatric central nervous system tumors: a cell kinetic study with bromodeoxyuridine.
Murovic JA; Nagashima T; Hoshino T; Edwards MS; Davis RL
Neurosurgery; 1986 Dec; 19(6):900-4. PubMed ID: 3027608
[TBL] [Abstract][Full Text] [Related]
7. Variability in the proliferative potential of human gliomas.
Hoshino T; Nagashima T; Cho KG; Davis RL; Donegan J; Slusarz M; Wilson CB
J Neurooncol; 1989 Jul; 7(2):137-43. PubMed ID: 2550593
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
[TBL] [Abstract][Full Text] [Related]
9. [Factors affecting the prognosis of brain tumors].
Yoshimine T; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
[TBL] [Abstract][Full Text] [Related]
10. Proliferative potential and outcome in pediatric astrocytic tumors.
Prados MD; Krouwer HG; Edwards MS; Cogen PH; Davis RL; Hoshino T
J Neurooncol; 1992 Jul; 13(3):277-82. PubMed ID: 1325544
[TBL] [Abstract][Full Text] [Related]
11. [Malignancy grading of glial tumors. I. Astrocytomas].
Martin H; Schmidt D
Zentralbl Allg Pathol; 1985; 130(6):451-62. PubMed ID: 3010600
[TBL] [Abstract][Full Text] [Related]
12. Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
Kharbanda K; Sarkar C; Dinda AK; Karak AK; Mathur M; Roy S
Acta Oncol; 1993; 32(3):301-6. PubMed ID: 8391834
[TBL] [Abstract][Full Text] [Related]
13. Proliferative index in astrocytic tumours.
Rathi KR; Radotra BD; Khosla VK
Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
[TBL] [Abstract][Full Text] [Related]
14. [Histological classification of human gliomas: state of art and controversies].
Figarella-Branger D; Bouvier C
Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study of S-phase cells in human gliomas].
Ibayashi N; Hirakawa K; Suzuki K; Nakamura K; Houri T
No To Shinkei; 1988 Aug; 40(8):763-9. PubMed ID: 2460117
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
[TBL] [Abstract][Full Text] [Related]
17. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
[TBL] [Abstract][Full Text] [Related]
19. The prognostic implications of histologic classification and bromodeoxyuridine labeling index of mixed gliomas.
Wacker MR; Hoshino T; Ahn DK; Davis RL; Prados MD
J Neurooncol; 1994; 19(2):113-22. PubMed ID: 7964986
[TBL] [Abstract][Full Text] [Related]
20. [Grading of astrocytomas and oligodendrogliomas].
Kolles H; Niedermayer I; Feiden W
Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
